Literature DB >> 14644512

Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers.

Pinpin Lin1, Han Chang, William L Ho, Meng-Hsiang Wu, Jang-Ming Su.   

Abstract

It has been shown that cytochrome P4501B1 (CYP1B1) is over-expressed in variety of tumors. The objective of this study was to examine the expression and localization of CYP1B1 in normal lungs and tumor tissues of non-small cell lung cancers (NSCLC). CYP1B1 was detectable in the microsomes of normal lungs and lung tumors with Western immunoblotting. Utilizing immunohistochemical staining, we found that CYP1B1 was constitutively expressed in the cytoplasm of smooth muscle cells, but not in pneumocytes. Bronchiolar epithelia from three out of 19 normal lungs expressed CYP1B1. Among 89 NSCLC tumor tissues, more than 50% expressed CYP1B1. In addition, CYP1B1 expression was more common in adenocarcinomas than in squamous cell carcinomas. Recently, we reported over-expression of aryl hydrocarbon receptors (AhR) in lung adenocarcinomas. In the present study, we observed an association between CYP1B1 and AhR expression in 89 NSCLC tumor tissues. These results suggest that CYP1B1 overexpression in NSCLC is accompanied by up-regulation of AhR expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644512     DOI: 10.1016/s0169-5002(03)00359-3

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  17 in total

1.  Expression of aryl hydrocarbon receptor in relation to p53 status and clinicopathological parameters in breast cancer.

Authors:  Zheng-Dong Li; Kai Wang; Xin-Wei Yang; Zhi-Gang Zhuang; Jian-Jun Wang; Xiao-Wen Tong
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

Review 2.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

Review 3.  Aryl hydrocarbon receptor and lung cancer.

Authors:  Junchieh J Tsay; Kam-Meng Tchou-Wong; Alissa K Greenberg; Harvey Pass; William N Rom
Journal:  Anticancer Res       Date:  2013-04       Impact factor: 2.480

4.  The Role of Mast Cells in Molding the Tumor Microenvironment.

Authors:  A Rigoni; M P Colombo; C Pucillo
Journal:  Cancer Microenviron       Date:  2014-09-07

Review 5.  Regulation of the Immune Response by the Aryl Hydrocarbon Receptor.

Authors:  Cristina Gutiérrez-Vázquez; Francisco J Quintana
Journal:  Immunity       Date:  2018-01-16       Impact factor: 31.745

6.  Lung genotoxicity of benzo(a)pyrene in vivo involves reactivation of LINE-1 retrotransposon and early reprogramming of oncogenic regulatory networks.

Authors:  A A I Hassanin; M Tavera-Garcia; B Moorthy; G D Zhou; K S Ramos
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-10-09       Impact factor: 5.464

7.  Bioinformatics Analysis of the Effects of Tobacco Smoke on Gene Expression.

Authors:  Chunhua Cao; Jianhua Chen; Chengqi Lyu; Jia Yu; Wei Zhao; Yi Wang; Derong Zou
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

8.  The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells.

Authors:  Oliver Richmond; Maryam Ghotbaddini; Cidney Allen; Alice Walker; Shokouh Zahir; Joann B Powell
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

9.  Ambient Particulate Matter Induces Vascular Smooth Muscle Cell Phenotypic Changes via NOX1/ROS/NF-κB Dependent and Independent Pathways: Protective Effects of Polyphenols.

Authors:  Chia-Chi Ho; Yu-Cheng Chen; Ming-Hsien Tsai; Hui-Ti Tsai; Chen-Yi Weng; Shaw-Fang Yet; Pinpin Lin
Journal:  Antioxidants (Basel)       Date:  2021-05-14

10.  Evaluation of aryl hydrocarbon receptor expression in oral squamous cell carcinoma and normal oral mucosa using western blot.

Authors:  Vinod Mony; R Madhavan Nirmal; V Parvathi; R L Parvathy; B R Varun; P Jayanthi
Journal:  J Oral Maxillofac Pathol       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.